Efficacy and safety of controlled-release oxycodone and standard therapies for postoperative pain after knee or hip replacement

Canadian Journal of Surgery

Volumn 48, Issue 4, 2005, Pages 277-283

  De Beer, Justin De V ^a   Winemaker, Mitchell J ^a   Donnelly, Graeme A E ^b   Miceli, Paula C ^b   Reiz, Joseph L ^b   Harsanyi, Zoltan ^b   Payne, Lance W ^b   Darke, Andrew C ^b  

^a HAMILTON HEALTH SCIENCES   (Canada)

^b PURDUE PHARMA L P   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; BUPIVACAINE; COCODAMOL; CODEINE; FENTANYL; MORPHINE; OPIATE; OXYCODONE; OXYCODONE PLUS PARACETAMOL; PARACETAMOL; PETHIDINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANADA; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFUSION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; COST CONTROL; DISEASE SEVERITY; DIZZINESS; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG UTILIZATION; DYSPEPSIA; EPIDURAL ANESTHESIA; EVALUATION; FEMALE; FEVER; HEALTH CARE UTILIZATION; HUMAN; INSOMNIA; KNEE ARTHROPLASTY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NAUSEA; OPEN STUDY; OUTCOMES RESEARCH; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE PAIN; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; SOMNOLENCE; SWEATING; TACHYCARDIA; TOTAL HIP PROSTHESIS; VISUAL ANALOG SCALE; VOMITING;

AGED; ANALGESICS; ANALGESICS, OPIOID; ARTHROPLASTY, REPLACEMENT; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; OXYCODONE; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; TREATMENT OUTCOME;

EID: 24744455247     PISSN: 0008428X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bernard AA, Zrinzo LU. Joint replacement. The final solution? Adv Exp Med Biol 1999;455:415-61.
2. Canadian Joint Replacement Registry (CJRR). New national initiative to provide better information on hip and knee surgeries. Newswire 2000:June 2.
3. Canadian Institute for Health Information. Number of total hip and total knee replacement procedures performed in Canada, 1994/1995 to 1999/2000 [Figure 1]. Hospital Morbidity Database, 2002 Jan 30. Available: http://secure.cihi.ca/ cihiweb /en/media_30jan2002_figl_e.html (accessed 2005 May 8).
4. Gold BS, Kitz DS, Lecky JH, Neuhaus JM. Unanticipated admission to the hospital following ambulatory surgery. JAMA 1989;262:3008-10.
5. Ghosh S, Sallam S. Patient satisfaction and postoperative demands on hospital and community services after day surgery. Br J Surg 1994;81:1635-8.
6. Williams BA, Deriso BM, Figallo CM, Anders JW, Engel LB, Sproul KA, et al. Benchmarking the perioperative process. III. Effects of regional anesthesia clinical pathway techniques on process efficiency and recovery profiles in ambulatory orthopedic surgery. J Clin Anesth 1998;10: 570-8.
7. Acute Pain Management Guideline Panel. Acute pain management: operative or medical procedures and trauma. Clinical practice guideline. Rockville (MD): Agency for Health Care Policy and Research, U.S. Department of Health and Human Resources, Public Health Service; 1992. AHCPR Publication No. 92-0032.
8. Reuben SS, Connelly NR, Maciolek H. Postoperative analgesia with controlled-release oxycodone for outpatient anterior cruciate ligament surgery. Anesth Analg 1999;88:1286-91.
9. Cheville A, Chen A, Oster G, McGarry L, Narcessian E. A randomized trial of controlled-release oxycodone during inpatient rehabilitation following unilateral total knee arthroplasty. J Bone Joint Surg Am 2001;83:572-6.
10. Kaiko RF, Benziger DP, Fitzmartin RD, Burke BE, Reder RF, Goldenheim PD. Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone. Clin Pharmacol Ther 1996;59:52-61.
11. Patt RB. Using controlled-release oxycodone for the management of chronic cancer and noncancer pain. Am Pain Soc Bull 1996;6:1-6.
12. Sunshine A, Olson NZ, Colon A, Rivera J, Kaiko RF, Fitzmartin RD, et al. Analgesic efficacy of controlled-release oxycodone in postoperative pain. J Clin Pharmacol 1996;36:595-603.
13. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23:129-38.
14. OxyContin® product monograph. In: Compendium of Pharmaceuticals and Specialties. 37th ed. Ottawa: Canadian Pharmacists Association; 2002. p. 1243-5.
15. Crews JC. Multimodal pain management strategies for office-based and ambulatory procedures. JAMA 2002;288:629-32.